X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

SEC Streamlines Financial Statements Requirements in Connection with M&A Transactions

On May 21, 2020, the Securities and Exchange Commission (the “SEC”) adopted amendments (the “Amen...

Read More >

Remedial Amendment Period for 403(b) Plans ending on March 31, 2020

March 31, 2020 is the deadline for retroactively correcting most 403(b) plan document defects that o...

Read More >

Should You Use Integrated Project Delivery on Your Next Construction Project?

Complex construction projects have many moving parts and numerous stakeholders.  Each project often ...

Read More >

Mandatory Arbitration Provision Enforceable in Sexual Harassment Case Despite Recent NY Law

On June 26, 2019, Judge Denise Cote, of the Southern District of New York, granted a motion to compe...

Read More >

DHS Finalizes H-1B Registration Fee for FY 2021 Cap Season

The U.S. Department of Homeland Security (DHS) has finalized plans to charge employers a $10 registr...

Read More >

COVID-19: Developer Claims Toolbox

COVID-19: Two Sides of the Same Coin - Introduction - Globally, the construction industry is lar...

Read More >